MarketPing
शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
  1. Home
  2. Results news
  3. Prima Innovation
  4. Q2 FY27 results

Prima Innovation Q2 FY27 results: net profit ₹0.08 crore

Prima Innovation Limited reported standalone revenue of ₹19.40 crore in Q2 FY27, up 26.8% from Q1 FY27, while net profit fell 82.6% to ₹0.08 crore. EBITDA declined 27.4% to ₹1.19 crore and the margin narrowed by 4.6 percentage points to 6.1%.

Key points

  • Revenue rose 26.8% sequentially to ₹19.40 crore in Q2 FY27.
  • EBITDA fell 27.4% from ₹1.64 crore to ₹1.19 crore.
  • EBITDA margin declined by 4.6 percentage points to 6.1%.
  • Net profit fell 82.6% from ₹0.46 crore to ₹0.08 crore.
  • Basic EPS was ₹0.07 for Q2 FY27.

How did Prima Innovation perform in Q2 FY27?

Prima Innovation reported standalone revenue of ₹19.40 crore in Q2 FY27, up 26.8% from ₹15.30 crore in Q1 FY27. Total income rose 27.0% to ₹19.45 crore, while total expenses increased 31.5% to ₹19.35 crore. EBITDA fell 27.4% from ₹1.64 crore to ₹1.19 crore, and the EBITDA margin narrowed by 4.6 percentage points to 6.1%.

Cost of materials increased 51.7% from ₹8.38 crore to ₹12.71 crore, other expenses rose 63.0% from ₹3.73 crore to ₹6.08 crore, employee cost increased 18.1% to ₹1.70 crore, and finance costs rose 10.9% to ₹0.61 crore. There was no exceptional item. These results were presented on a standalone basis; the same-day filings do not provide consolidated figures for the quarter.

Prima Innovation Q2 FY27 results, standalone (₹ crore unless stated)
₹ croreQ2 FY27Q1 FY27QoQ
Revenue from operations19.4015.30+26.8%
Other income0.050.01+400.0%
Total expenses19.3514.71+31.5%
EBITDA1.191.64−27.4%
EBITDA margin6.1%10.7%−4.6 pp
Profit before tax0.110.61−82.0%
Tax0.030.15−80.0%
Net profit0.080.46−82.6%
EPS (₹)0.07227.85−100.0%

EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).

What do the balance sheet and cash flow show?

At 30 September 2026, total assets stood at ₹68.48 crore, compared with ₹65.40 crore at 31 March 2026. Total equity was ₹27.11 crore against ₹26.58 crore, while borrowings declined from ₹25.39 crore to ₹24.22 crore. Cash stood at ₹0.02 crore, compared with ₹0.03 crore at the previous balance-sheet date.

Inventories increased from ₹13.55 crore to ₹15.62 crore, while trade receivables declined from ₹15.22 crore to ₹14.52 crore. Trade payables rose from ₹4.17 crore to ₹6.02 crore. For H1 FY27, operating cash flow was ₹3.68 crore, investing cash flow was negative ₹1.37 crore and financing cash flow was negative ₹2.33 crore; capital expenditure was ₹1.82 crore. No year-earlier cash-flow figures were provided.

Balance sheet (₹ crore)
₹ croreAs of 30 September 2026As of 31 March 2026
Total assets68.4865.40
Total equity27.1126.58
Borrowings24.2225.39
Cash and equivalents0.020.03
Inventories15.6213.55
Trade receivables14.5215.22

Source: Company's results filing (XBRL).

Cash flow, year to date (₹ crore)
₹ croreH1 FY27
Cash from operations3.68
Cash from investing−1.37
Cash from financing−2.33
Capital expenditure1.82

Source: Company's results filing (XBRL).

What else did the company announce?

The board approved the standalone unaudited financial results for the quarter and half year ended 30 September 2026 on 29 October 2026. The company also filed that Mr. Dilip M. Parekh resigned as Non-Executive Non-Independent Director from the close of business hours on 29 October 2026, citing personal reasons. The same-day filings do not mention a dividend or a fund raise.

What did the auditors point out?

CNK & Associates LLP said that nothing had come to its attention causing it to believe that the statement had failed to disclose information required under the Listing Regulations or contained any material misstatement. The auditor described the engagement as a limited review under SRE 2410, obtained moderate assurance and did not express an audit opinion.

The report included an Emphasis of Matter concerning the Scheme of Arrangement approved by the National Company Law Tribunal on 16 March 2026 for transfer of the Rotational business from Prima Plastics Limited. The auditor noted that Ind AS 103 required accounting from the date of transfer of control, while the demerger was accounted for from the appointed date of 1 July 2024. Financial information for the quarter and period ended 30 September 2025 was restated by management but had not been audited or reviewed by CNK & Associates.

How did Prima Innovation shares react?

The results were filed after market hours on 29 October 2026. The stock showed no movement at 5, 15 and 30 minutes after the filing, but fell 6.2% by the close of the first session that could trade on the news. By the next day’s close, it was down 0.0% from its pre-results close; no five-day or one-month reaction was provided.

Share price after the results filing
After the filingStock
5 minutes+0.0%
15 minutes+0.0%
30 minutes+0.0%
Reaction day−6.2%
Next day−0.0%

Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.

Quick answers

What was Prima Innovation's revenue in Q2 FY27?

Revenue from operations was ₹19.40 crore (standalone).

Did Prima Innovation make a profit in Q2 FY27?

Yes. Net profit was ₹0.08 crore.

What was Prima Innovation's EPS in Q2 FY27?

Basic earnings per share were ₹0.07.

How did Prima Innovation shares react to the Q2 FY27 results?

On the reaction day the stock moved −6.2% from the previous close.

When did Prima Innovation announce its Q2 FY27 results?

On 29 October 2026, in a filing to the BSE.

Sources

How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.

This is information, not investment advice. MarketPing does not recommend buying or selling any security.